3%的高渗盐水联合肾上腺素治疗毛细支气管炎的临床研究被引量：2

Clinical study on 3% hypertonic saline combined with epinephrine through atomizing inhalation to treat bronchiolitis

导出

摘要目的观察3%高渗盐水(HS)联合小剂量肾上腺素雾化吸入治疗毛细支气管炎的效果。方法选择109例毛细支气管炎住院治疗的患儿,随机分为对照组与治疗组。治疗组用小剂量肾上腺素溶于HS进行雾化吸入治疗,对照组用万托林溶于0.9%生理盐水(NS)中雾化吸入治疗。比较2组患儿临床症状改善情况、住院天数及治疗前后患儿的肺功能。结果治疗后2组临床症状、体征均明显改善;治疗组改善更明显,平均住院日更短、肺功能改善更优。结论 HS联合小剂量肾上腺素吸入治疗毛细支气管炎疗效更显著。 Objective To explore the clinical effect of the 3% hypertonic saline combined with inhalation of low doses of epinephrine on bronchiolitis in infants.Methods A total of 109 infants with bronchiolitis in our hospital were randomly divided into treatment group and control group.The treatment group was treated by using epinephrine to dissolve in 3% hypertonic saline as inhalation therapy,and the control group by using salbutamol sulphate aerosol to dissolve in 0.9% saline as inhalation therapy.The symptom improvement,duration of hospitalization and changes in pulmonary function in the two groups before and after treatment were compared.Results After treatment,clinical symptoms and signs improved in the two groups,improvement in the treatment group being more significant,with shorter average hospital stay and better improvement in the average lung functions compared with the control group.Conclusion The 3% hypertonic saline combined with low doses of epinephrine inhalation has a therapeutic effect in the treatment of bronchiolitis.

作者顾冬云陈志宏陈沛文

机构地区江苏省靖江市人民医院儿科

出处《实用临床医药杂志》 CAS 2012年第15期156-157,共2页 Journal of Clinical Medicine in Practice

关键词毛细支气管炎3%高渗盐水肾上腺素万托林 bronchiolitis 3% hypertonic saline epinephrine salbutamol sulphate aerosol

分类号 R562.2 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献4

1胡亚美,江载芳.褚福棠实用儿科学[M].第7版.北京:人民卫生出版社,2005:701.
2沈晓明,王卫平.儿科学[M].北京:人民卫生出版社,2008:199.
3胡晓红,陈志敏.肾上腺素与万托林雾化吸入治疗婴幼儿喘息疗效分析[J].实用医学杂志,2007,23(15):2423-2425. 被引量：8
4张立明李永珍.吸入肾上腺素降低呼吸道合胞病毒毛细支气管炎气道阻塞的药理机制[J].国外医学：妇幼保健分册,2001,12.

二级参考文献15

1林耀广.支气管哮喘的治疗学及其进展（现代呼吸系疾病系统讲座第六讲）[J].中华结核和呼吸杂志,1995,18(4):202-206. 被引量：68
2小儿哮喘的治疗[J].中国实用儿科杂志,1996,11(1):1-21. 被引量：110
3张立明李永珍.吸入肾上腺素降低呼吸道合胞病毒毛细支气管炎气道阻塞的药理机制[J].国外医学：妇幼保健分册,2001,12.
4Becker A B,Nelson N A,Simons F E.The pulmonary index.Assessment of a clinical score for asthma[J].Am J Dis Child,1984,138(6):574-576.
5陈新谦,金有豫.新编药物学[M].13版.北京:人民卫生出版社,1992:274.
6Hofhuis W,van der Wiel E C,Tiddens H A,et al.Bronchodilation in infants with malacia or recuurent wheeze[J].Arch Dis Child,2003,88 (3):246-249.
7Chavasse R,Seddon P,Bara A,et al.Short acting beta agonists for recurrent wheeze in children under 2 years of age[J].Cochrane Database Syst Rev,2002 (3):2873.
8Barrueto L,Mallol J,Figueroa L.Beclimethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing[J].Pediatr Pulmonol,2002,34(1):52-57.
9Totapally B R,Demeerci C,Zureikat G,et al.Tidal breathing flowvolume loops in infancy:the effect of albuterol[J].Crit Care,2002,6(2):160-165.
10Chavasse R J,Bastian-Lee Y,Richter H,et al.Inhaled salbutamol for wheezy infants:a randomized controlled trial[J].Arch Dis Child,2000,82(5):370-375.